
Avantor Inc. (AVTR) Stock Forecast & Price Target
Avantor Inc. (AVTR) Analyst Ratings
Bulls say
Avantor is a leading provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. Despite challenges in the academic and biotech markets, Avantor holds a solid market share and is in a strong position for long-term growth. The company is currently undergoing a management transition and facing competition and trade war headwinds, but we believe this is reflected in the company's discounted valuation.
Bears say
Avantor is heavily dependent on its Laboratory Solutions segment, which has been struggling with low organic growth and operational challenges. This has led to a slower growth rate compared to its peers and raises doubts about the company's ability to compete with formidable competitors like Thermo-Fisher. The uncertain demand for its products and continued share losses may also hinder its growth in the future. Additionally, the company's sustainability goals may not be enough to offset concerns regarding chemical waste management and emissions reduction, which could further damage its reputation and financial performance. Overall, Avantor's negative outlook is driven by its underperformance in its key segment, potential challenges in the future, and lingering sustainability issues that could impact its growth and profitability.
This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.
Avantor Inc. (AVTR) Analyst Forecast & Price Prediction
Start investing in Avantor Inc. (AVTR)
Order type
Buy in
Order amount
Est. shares
0 shares